Workflow
文峰股份(601010) - 2018 Q3 - 季度财报
WFDSJWFDSJ(SH:601010)2018-10-29 16:00

Financial Performance - Operating revenue for the first nine months was ¥4,801,792,542.67, a decrease of 2.64% year-on-year[8] - Net profit attributable to shareholders for the first nine months was ¥196,287,063.79, down 8.70% from the previous year[8] - Basic earnings per share for the period was ¥0.1062, down 8.68% year-on-year[8] - Total operating revenue for Q3 was approximately ¥1.34 billion, a slight increase from ¥1.33 billion in the same period last year, but a decrease from ¥4.93 billion year-to-date last year to ¥4.80 billion this year[29] - Net profit for Q3 was approximately ¥32.17 million, down from ¥43.33 million in the same period last year, with year-to-date net profit decreasing from ¥215.10 million to ¥196.32 million[30] - The company’s total comprehensive income for Q3 was approximately ¥32.17 million, down from ¥43.33 million in the same period last year[30] - The total profit for Q3 was approximately ¥409.32 million, a decrease from ¥68.82 million in the same period last year, reflecting a decline of 99.4%[33] Cash Flow - The net cash flow from operating activities for the first nine months was ¥345,785,841.87, a decrease of 22.00% compared to the same period last year[8] - Cash flow from operating activities decreased by 22.00% to ¥345,785,841.87, attributed to a net decrease in merchandise sales income[14] - The total cash inflow from operating activities was ¥5.55 billion, while cash outflow was ¥5.21 billion, resulting in a net cash flow from operating activities of ¥345.79 million[35] - The company reported a net cash outflow from investing activities of approximately ¥273.36 million, compared to a smaller outflow of ¥68.84 million in the previous year[35] - Cash flow from financing activities resulted in a net outflow of CNY -162,942,260.27, improving from CNY -319,307,701.02 in the same period last year[40] Assets and Liabilities - Total assets decreased by 3.61% compared to the end of the previous year, amounting to ¥6,272,412,290.64[8] - The total liabilities decreased from CNY 2,159,145,397.13 to CNY 1,819,319,502.71, a reduction of approximately 15.7%[21] - The total owner's equity increased from CNY 4,348,162,040.71 to CNY 4,453,092,787.93, reflecting a growth of about 2.4%[21] - Cash and cash equivalents decreased from CNY 379,680,931.73 to CNY 224,535,533.17, a decline of approximately 40.9%[24] - The total current assets decreased from CNY 980,944,184.17 to CNY 893,377,299.73, a decrease of about 8.9%[24] - The total non-current assets increased from CNY 4,093,965,124.42 to CNY 4,112,571,076.17, an increase of approximately 0.5%[24] Shareholder Information - The total number of shareholders at the end of the reporting period was 136,518[10] - The largest shareholder, Jiangsu Wenfeng Group Co., Ltd., held 22.71% of the shares[10] - The company’s major shareholder, Jiangsu Wenfeng Group, increased its stake by acquiring 18,891,791 shares, representing 1.0223% of the total share capital[16] Government Support and Other Income - The company received government subsidies amounting to ¥12,241,992.70 from the beginning of the year to the reporting period[8] - Non-operating income and expenses totaled ¥313,448.77 for the current period[8] - The company recorded investment income of approximately ¥4.08 million year-to-date, an increase from ¥2.55 million last year[29] Financial Management - Financial expenses decreased by 45.58% to ¥11,246,485.80, mainly due to an increase in interest income and a reduction in interest expenses and bank fees[14] - The company incurred financial expenses of ¥924.48 million in Q3, significantly lower than ¥2.74 million in the same period last year, primarily due to reduced interest expenses[33] - The company reported an increase in tax expenses to ¥23.65 million for the first nine months, compared to ¥22.95 million in the same period last year, reflecting a rise of 3.1%[33] Future Outlook - The company plans to continue expanding its market presence and is actively exploring new investment opportunities[15]